Cargando…

CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial

BACKGROUND: The clinical factors that accurately predict the response to preoperative treatment in rectal cancer were yet unknown. The carcinoembryonic antigen (CEA) clearance pattern during neoadjuvant treatment has been developed and the predictive value explored in rectal cancer patients with ele...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Huabin, Huang, Jin, Lan, Ping, Wang, Lei, Huang, Meijin, Wang, Jianping, Deng, Yanhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247708/ https://www.ncbi.nlm.nih.gov/pubmed/30458734 http://dx.doi.org/10.1186/s12885-018-4997-y

Ejemplares similares

Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer
por: Zhuang, Zhuokai, et al.
Publicado: (2021)

Nomogram basing pre-treatment parameters predicting early response for locally advanced rectal cancer with neoadjuvant chemotherapy alone: a subgroup efficacy analysis of FOWARC study
por: Zhang, Jianwei, et al.
Publicado: (2015)

Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial
por: Deng, Yanhong, et al.
Publicado: (2019)

Development and external validation of prognostic nomograms for liver disease-free and overall survival in locally advanced rectal cancer with neoadjuvant therapy: a post cohort study based on the FOWARC trial
por: Zhou, Jiaming, et al.
Publicado: (2022)

Effect of interval between preoperative radiotherapy and surgery on clinical outcome and radiation proctitis in rectal cancer from FOWARC trial
por: Cheng, Yi‐Kan, et al.
Publicado: (2019)

Prognostic Value of Postoperative CEA Clearance in Rectal Cancer Patients with High Preoperative CEA Levels
por: Kim, Jeong Yeon, et al.
Publicado: (2009)

Density and distribution of lymphocytes in pretherapeutic rectal cancer and response to neoadjuvant therapy
por: Lai, Sicong, et al.
Publicado: (2020)

The prognostic and predictive value of mismatch repair status in patients with locally advanced rectal cancer following neoadjuvant therapy
por: Wu, Zehua, et al.
Publicado: (2022)

CEA Decline Predicts Tumor Regression and Prognosis in Locally Advanced Rectal Cancer Patients with Elevated Baseline CEA
por: Cai, Zerong, et al.
Publicado: (2020)

Time to lowest postoperative carcinoembryonic antigen level is predictive on survival outcome in rectal cancer
por: Yu, Huichuan, et al.
Publicado: (2016)

The effect of serum CEA on the distribution and clearance of anti-CEA antibody in a pancreatic tumour xenograft model.
por: Pedley, R. B., et al.
Publicado: (1989)

Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy alone for patients with locally advanced rectal cancer: a propensity-score-matched analysis combined with SEER validation
por: Wu, Jingjing, et al.
Publicado: (2023)

Reduction of circulating lymphocyte count is a predictor of good tumor response after neoadjuvant treatment for rectal cancer
por: Wu, Zehua, et al.
Publicado: (2018)

Multiple myeloma presenting as CEA-producing rectal cancer
por: Talamo, Giampaolo, et al.
Publicado: (2010)

Prognosis and postoperative genital function of function-preservative surgery of pelvic autonomic nerve preservation for male rectal cancer patients
por: Liu, Zhihua, et al.
Publicado: (2016)

Neoadjuvant therapy followed by local excision and two-stage total mesorectal excision: a new strategy for sphincter preservation in locally advanced ultra-low rectal cancer
por: Wang, Ting, et al.
Publicado: (2014)

Complete response in patients with locally advanced rectal cancer after neoadjuvant treatment with nivolumab
por: Zhang, Jianwei, et al.
Publicado: (2019)

Prognostic value of CEA and CA19-9 in patients with local advanced rectal cancer receiving neoadjuvant chemoradiotherapy, radical surgery and postoperative chemotherapy
por: Shan, Jingjing, et al.
Publicado: (2021)

Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery
por: Yang, Kai-Lin, et al.
Publicado: (2013)

Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial
por: Auclin, Edouard, et al.
Publicado: (2019)

Tumor Volume Reduction Rate Predicts Pathologic Tumor Response of Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemotherapy alone: Results from a Prospective Trial
por: Xiao, Jian, et al.
Publicado: (2015)

Elevated CEA is associated with worse survival in recurrent rectal cancer
por: Cho, Won Kyung, et al.
Publicado: (2017)

Combination of Changes in CEA and CA199 Concentration After Neoadjuvant Chemoradiotherapy Could Predict the Prognosis of Stage II/III Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy Followed by Total Mesorectal Excision
por: Zhao, Jieyi, et al.
Publicado: (2022)

Predicting rectal tumor response to neoadjuvant chemoradiotherapy using plasma levels of carcinoembryonic antigen (CEA): Results from a tertiary center in Iran
por: Ahmadi Amoli, Hadi, et al.
Publicado: (2022)

Association of T Stage and Serum CEA Levels in Determining Survival of Rectal Cancer
por: Wu, Shengwen, et al.
Publicado: (2020)

Data on patterns of initial recurrence after curative surgery for rectal cancer with neoadjuvant therapy
por: Zheng, Zhifang, et al.
Publicado: (2020)

Comparison of guidelines on rectal cancer: exception proves the rule?
por: Dou, Ruoxu, et al.
Publicado: (2021)

Predictive Value of FOLFOX-Based Regimen, Long Interval, Hemoglobin Levels and Clinical Negative Nodal Status, and Postchemoradiotherapy CEA Levels for Pathological Complete Response in Patients with Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy
por: Huang, Chun-Ming, et al.
Publicado: (2020)

Differing Serum Cea in Primary and Recurrent Rectal Cancer - A Reflection of Histology?
por: Chang, Angela C, et al.
Publicado: (2012)

CEA, EpCAM, αvβ6 and uPAR Expression in Rectal Cancer Patients with a Pathological Complete Response after Neoadjuvant Therapy
por: Linders, Daan, et al.
Publicado: (2021)

Radiation-induced injury on surgical margins: a clue to anastomotic leakage after rectal-cancer resection with neoadjuvant chemoradiotherapy?
por: Qin, Qiyuan, et al.
Publicado: (2019)

Impact of long-course neoadjuvant radiation on postoperative low anterior resection syndrome and stoma status in rectal cancer: long-term functional follow-up of a randomized clinical trial
por: He, Siqi, et al.
Publicado: (2022)

Plasma CEA in the post-surgical monitoring of colorectal carcinoma.
por: Tate, H.
Publicado: (1982)

Morphologic predictors of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Zhang, Chongda, et al.
Publicado: (2017)

The Role of Cea and Liver Function Tests in the Detection of Hepatic Metastases From Colo-Rectal Cancer
por: Bonfanti, G., et al.
Publicado: (1990)

Elevated preoperative CEA is associated with worse survival in stage I–III rectal cancer patients
por: Tarantino, I, et al.
Publicado: (2012)

Clinical Significances of Positive Postoperative Serum CEA and Post-preoperative CEA Increment in Stage II and III Colorectal Cancer: A Multicenter Retrospective Study
por: You, Weiqiang, et al.
Publicado: (2020)

Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localisation in a xenograft model.
por: Sharma, S. K., et al.
Publicado: (1990)

CEA solenoide
por: Sylvie Prodon
Publicado: (2003)

Fat clearance and conventional fixation identified ypN0 rectal cancers following intermediate neoadjuvant radiotherapy have similar long-term outcomes
por: Chen, Nan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p67f3a4s2gh5fnr9je06ughnfn